Capital International, Inc. Incyte Corp Transaction History

Capital International, Inc.

$7.57 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$66.18 - $82.86 $543,139 - $680,032	-8,207 Reduced 24.53%	25,255 $1.68 Million
Q2 2022 Aug 15, 2022	SELL	$66.18 - $83.18 $33,023 - $41,506	-499 Reduced 1.47%	33,462 $2.54 Million
Q1 2022 May 16, 2022	SELL	$66.02 - $79.71 $5.22 Million - $6.3 Million	-79,025 Reduced 69.94%	33,961 $2.7 Million
Q4 2021 Feb 14, 2022	BUY	$63.34 - $74.11 $73,791 - $86,338	1,165 Added 1.04%	112,986 $8.29 Million
Q3 2021 Nov 15, 2021	SELL	$68.67 - $84.02 $201,546 - $246,598	-2,935 Reduced 2.56%	111,821 $7.69 Million
Q2 2021 Aug 16, 2021	SELL	$79.87 - $87.53 $2.03 Million - $2.23 Million	-25,474 Reduced 18.17%	114,756 $9.65 Million
Q1 2021 May 14, 2021	SELL	$76.02 - $100.5 $958,992 - $1.27 Million	-12,615 Reduced 8.25%	140,230 $11.4 Million
Q4 2020 Feb 16, 2021	BUY	$80.74 - $97.7 $461,025 - $557,867	5,710 Added 3.88%	152,845 $13.3 Million
Q3 2020 Nov 13, 2020	SELL	$85.07 - $109.69 $2.53 Million - $3.26 Million	-29,707 Reduced 16.8%	147,135 $13.2 Million
Q2 2020 Aug 14, 2020	SELL	$74.18 - $108.93 $13.4 Million - $19.6 Million	-180,182 Reduced 50.47%	176,842 $18.4 Million
Q1 2020 May 15, 2020	SELL	$63.18 - $85.97 $8.52 Million - $11.6 Million	-134,876 Reduced 27.42%	357,024 $26.1 Million
Q4 2019 Feb 18, 2020	SELL	$73.04 - $95.72 $1.05 Million - $1.38 Million	-14,431 Reduced 2.85%	491,900 $43 Million
Q3 2019 Nov 14, 2019	BUY	$72.82 - $86.52 $29.3 Million - $34.9 Million	402,867 Added 389.38%	506,331 $37.6 Million
Q2 2019 Aug 14, 2019	BUY	$73.52 - $88.7 $4.58 Million - $5.53 Million	62,300 Added 151.35%	103,464 $8.79 Million
Q1 2019 May 15, 2019	SELL	$63.56 - $88.17 $572,040 - $793,530	-9,000 Reduced 17.94%	41,164 $3.54 Million
Q4 2018 Feb 14, 2019	SELL	$58.5 - $69.94 $1.49 Million - $1.78 Million	-25,463 Reduced 33.67%	50,164 $3.19 Million
Q3 2018 Nov 14, 2018	BUY	$61.75 - $74.23 $587,860 - $706,669	9,520 Added 14.4%	75,627 $5.22 Million
Q2 2018 Aug 14, 2018	BUY	$60.85 - $83.98 $405,565 - $559,726	6,665 Added 11.21%	66,107 $4.43 Million
Q1 2018 May 15, 2018	SELL	$83.06 - $100.98 $697,704 - $848,232	-8,400 Reduced 12.38%	59,442 $4.95 Million
Q4 2017 Feb 14, 2018	SELL	$93.56 - $116.6 $752,690 - $938,047	-8,045 Reduced 10.6%	67,842 $6.43 Million
Q3 2017 Nov 14, 2017	BUY	$109.15 - $138.27 $8.28 Million - $10.5 Million	75,887	75,887 $8.86 Million

Others Institutions Holding INCY

# of Institutions

644

Shares Held

186M

Call Options Held

714K

Put Options Held

557K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16.1B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital International, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Capital International, Inc. with notifications on news.

Account